ClinicalTrials.govpublic full text
Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
healthy volunteers, multiple sclerosis, first in human, 2b3-201, methylprednisolone, cns-targeting, liposomal, crossover, placebo controlled, active controlled, multiple sclerosis relapse, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858505
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.